Kraków, Poland

Krzysztof Brzózka



Average Co-Inventor Count = 11.0

ph-index = 2

Forward Citations = 7(Granted Patents)


Location History:

  • Sieradz, PL (2013)
  • Kraków, PL (2016 - 2019)

Company Filing History:


Years Active: 2013-2019

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Krzysztof Brzózka

Introduction

Krzysztof Brzózka is an accomplished inventor based in Kraków, Poland. With a notable portfolio of four patents, he has made significant contributions to the field of medicinal chemistry. His work primarily focuses on developing innovative compounds that serve as kinase inhibitors, showcasing his expertise and dedication to advancing medical science.

Latest Patents

Among Krzysztof Brzózka's latest innovations are two key patents focusing on benzimidazole derivatives. The first patent addresses "Benzimidazole derivatives as kinase inhibitors." This invention involves compounds that demonstrate inhibitory effects on serine/threonine and tyrosine kinases, particularly PIM1-3 and DYRK1A. These compounds have promising applications in treating serious diseases associated with these kinases, including leukemias, lymphomas, solid tumors, and autoimmune disorders.

His second patent, "Substituted tricyclic benzimidazoles as kinase inhibitors," reveals the potential of tricyclic benzimidazole compounds. These compounds selectively inhibit CDK8, offering a pathway for the treatment of colorectal and melanoma cancers, along with other solid and hematological malignancies, as well as autoimmune and inflammatory diseases. The patents also encompass processes for preparing these innovative compounds, further extending their impact in the pharmaceutical field.

Career Highlights

Krzysztof Brzózka is associated with Selvita S.A., a leading biopharmaceutical company specializing in drug discovery and development. His position at Selvita has allowed him to work on cutting-edge research and development, contributing to impactful innovations in the pharmaceutical arena.

Collaborations

In his innovative journey, Krzysztof collaborates with talented colleagues such as Wojciech Czardybon and Michal Galezowski. This teamwork not only enhances the research environment but also accelerates the progression of their groundbreaking projects.

Conclusion

Krzysztof Brzózka's work exemplifies the spirit of innovation in the field of medicinal chemistry. His patents on kinase inhibitors represent a significant stride towards developing effective treatments for various cancers and autoimmune diseases. As he continues to push the boundaries of science at Selvita S.A., his contributions will undoubtedly leave a lasting mark on the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…